marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 03-27-2024
Ampio Pharmaceuticals Financial Statements 2011-2024 | AMPE
Annual Financial Statements Ampio Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
664 K | 188 K | 6.64 M | 271 M | 88.8 M | 36.7 M | 191 M | 51.1 M | 124 M | 252 M | 336 M | 131 M | 106 M |
Shares |
810 K | 754 K | 13.3 M | 173 M | 131 M | 73.4 M | 65.3 M | 53.8 M | 52 M | 50.2 M | 38.3 M | 34 M | 26 M |
Historical Prices |
0.82 | 0.25 | 0.5 | 1.71 | 0.6 | 0.63 | 2.22 | 0.82 | 2.13 | 5.64 | 7.12 | 3.88 | 3.86 |
Net Income |
-8.63 M | -16.3 M | -17.1 M | -15.9 M | -13.6 M | 34 M | -51.9 M | -19.2 M | -32 M | -38.1 M | -24 M | -11.6 M | -18.4 M |
Revenue |
- | - | - | - | - | - | - | - | 1.16 M | 76.8 K | 50 K | 50 K | 18.8 K |
Cost of Revenue |
- | - | - | - | - | - | - | - | 369 K | - | - | - | - |
Gross Profit |
- | - | - | - | - | -523 K | -568 K | -950 K | 793 K | -2.16 M | - | - | 18.8 K |
Operating Income |
- | - | - | - | - | - | - | - | -33.3 M | -39.1 M | -24 M | - | - |
Interest Expense |
- | - | - | - | - | -5.01 K | 3.09 K | 23.5 K | 11.5 K | 22 K | 12.3 K | - | 8.36 K |
EBITDA |
122 K | 1.05 M | 1.09 M | -14 M | -18.5 M | -9.9 M | -14.4 M | -15.9 M | -32.2 M | -38.6 M | -23.9 M | -11.8 M | -11.1 M |
Operating Expenses |
9.57 M | 22.3 M | 20.6 M | - | 18.6 M | 11.2 M | 15.6 M | 17.1 M | 34.1 M | 39.1 M | 24.1 M | 11.9 M | 11.2 M |
General and Administrative Expenses |
7.08 M | 11.5 M | 8.67 M | 6.65 M | 5.9 M | 4.36 M | 5.14 M | 6.54 M | 15.1 M | 12.2 M | 5.78 M | 4.38 M | 4.5 M |
All numbers in USD currency
Quarterly Income Statement Ampio Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
804 K | 15.1 M | 15.1 M | 805 K | 754 K | 15.1 M | 15.1 M | 15.2 M | 13.4 M | 196 M | 195 M | 193 M | 179 M | 166 M | 159 M | 159 M | 142 M | 115 M | 111 M | 111 M | 96.9 M | 86.3 M | 82.9 M | 74.9 M | 68.2 M | 60.6 M | 57.2 M | 57.2 M | 53.8 M | 52 M | 52 M | 52 M | 52 M | 52 M | 52 M | 52 M | 52 M | 51.9 M | 45 M | 42.1 M | 37.1 M | 37.1 M | 37.1 M | 37 M | 36.5 M | 31.3 M | 31.1 M | 31.1 M | 28.7 M | 28.3 M | 31.1 M |
Net Income |
-1.23 M | -1.37 M | -3.98 M | - | -6.41 M | -2.07 M | -5.64 M | - | -3.63 M | -3.56 M | -3.67 M | - | -3.37 M | -2.73 M | -5.18 M | - | -7.22 M | 421 K | -5.81 M | - | 5.8 M | 4.62 M | 22 M | -43.1 M | -4.25 M | -2.61 M | -1.9 M | -3.35 M | -3.99 M | -5.05 M | -6.76 M | -10 M | -7.16 M | -7.36 M | -7.28 M | -9.91 M | -9.28 M | -8.69 M | -10.2 M | -7.34 M | -6.07 M | -6.42 M | -24.5 M | -3.68 M | -11.6 M | -11.6 M | -11.6 M | - | -18.4 M | -18.4 M | -8.78 M |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -691 K | -353 K | 469 K | 466 K | 163 K | 21.4 K | 21.4 K | - | 21.4 K | 12.5 K | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 244 K | 37.3 K | 87.9 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -7.67 M | - | - | - | -9.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -3.19 K | - | - | - | - | 54 | 3.03 K | 3.69 K | 3.08 K | 6.56 K | 10.2 K | 4.25 K | -1.3 K | 12.4 K | 44.5 K | 5.72 K | 5.55 K | 7.5 K | 3.5 K | 4.36 K | -250 K | -136 K | -122 K | - | - | - | - | - | 8.36 K | 8.36 K | 8.36 K |
EBITDA |
- | - | - | - | 347 K | 256 K | 262 K | - | 831 K | 568 K | 294 K | - | 885 K | 591 K | 295 K | - | 975 K | 736 K | 365 K | - | 968 K | 621 K | 301 K | - | 911 K | 607 K | 304 K | - | 917 K | 611 K | 306 K | - | -7.05 M | 412 K | 206 K | - | -9.29 M | 83.1 K | 41.2 K | - | 97.3 K | 57.8 K | 18.5 K | - | 46.8 K | 31.2 K | 15.6 K | - | 27 K | 11.4 K | - |
Operating Expenses |
1.4 M | 1.56 M | 4.4 M | - | 7.66 M | 4.99 M | 6.97 M | - | 3.85 M | 3.67 M | 3.82 M | - | 3.3 M | 2.6 M | 6.02 M | - | 5.17 M | 3.58 M | 2.68 M | - | 1.94 M | 3.13 M | 3.57 M | 4.81 M | 3.11 M | 4.69 M | 3 M | 2.95 M | 3.34 M | 4.37 M | 6.42 M | 7.29 M | 5.3 M | 5.78 M | 5.79 M | 10.2 M | 9.52 M | 8.96 M | 10.5 M | 7.55 M | 5.96 M | 6.47 M | 4.1 M | 3.77 M | 2.81 M | 2.28 M | 3.01 M | - | 2.78 M | 1.58 M | 2.24 M |
General and Administrative Expenses |
1.07 M | 1.22 M | 3.82 M | - | 2.98 M | 3.24 M | 3.28 M | - | 1.26 M | 1.4 M | 1.52 M | - | 1.65 M | 1.48 M | 1.77 M | - | 1.74 M | 1.44 M | 1.11 M | - | 756 K | 1.02 M | 1.53 M | 1.37 M | 1.11 M | 1.34 M | 1.36 M | 1.31 M | 1.56 M | 1.56 M | 2.11 M | 2.87 M | 1.65 M | 2.67 M | 1.87 M | 2.94 M | 555 K | 662 K | 609 K | 2.46 M | 384 K | 512 K | 1.77 M | 1.44 M | 678 K | 727 K | 1.54 M | - | 1.37 M | 567 K | 1.6 M |
All numbers in USD currency